L. L. Porter

Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung

L. L. Porter, David H. Johnson, John D. Hainsworth et al. · Lung Cancer · 1986 · 72 citations

Medicine, Oncology, Pharmacology +12

Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.

David H. Johnson, S N Wolff, John D. Hainsworth et al. · Journal of Clinical Oncology · 1985 · 38 citations

Medicine, Oncology, Pharmacology +10

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial

H. Choy, R.F. DeVore, Kenneth R. Hande et al. · Lung Cancer · 2001 · 36 citations

Medicine, Oncology, Radiation Oncology +14

A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbuilt Cancer Center Affiliate Network (VCCAN) Trial

H. Choy, R.F. DeVore, Kenneth R. Hande et al. · Clinical Lung Cancer · 2000 · 24 citations

Medicine, Oncology, Radiation Oncology +16

High-dose etoposide (VP-16) in small-cell lung cancer.

F. Anthony Greco, David H. Johnson, Kenneth R. Hande et al. · PubMed · 1985 · 24 citations

Medicine, Oncology, Pharmacology +7